Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

1.26
Delayed Data
As of Mar 24
 -0.01 / -0.79%
Today’s Change
1.16
Today|||52-Week Range
8.49
0.00%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close1.27
Today’s open1.28
Day’s range1.25 - 1.29
Volume2,136,167
Average volume (3 months)6,794,164
Market cap$342.7M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-71.67%
Earnings growth (this year)+39.76%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-57.65%
P/E ratioNM
Price/Sales22.22
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.04-1.02%
GERNGeron Corp+0.01+0.47%
BTXBioTime Inc-0.04-1.24%
SYRSSyros Pharmaceutical...+0.71+4.87%
Data as of 4:00pm ET, 03/24/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$15.4M
Annual profit (last year)-$280.0M
Net profit margin-1,823.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts


Search for Jobs